©2014 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. May 14, 2014; 20(18): 5283-5293
Published online May 14, 2014. doi: 10.3748/wjg.v20.i18.5283
Published online May 14, 2014. doi: 10.3748/wjg.v20.i18.5283
Treatment of Helicobacter pylori infection: Current status and future concepts
Jyh-Chin Yang, Department of Internal Medicine, Hospital and College of Medicine, National Taiwan University, Taipei 100, Taiwan
Chien-Wei Lu, Chun-Jung Lin, School of Pharmacy, National Taiwan University, Taipei 100, Taiwan
Author contributions: All the authors contributed equally to this manuscript.
Correspondence to: Chun-Jung Lin, PhD, School of Pharmacy, National Taiwan University, 1 Jen-Ai Road, Section 1, Taipei 100, Taiwan. clementumich@ntu.edu.tw
Telephone: +886-2-23123456 Fax: +886-2–23919098
Received: September 25, 2013
Revised: November 28, 2013
Accepted: January 19, 2014
Published online: May 14, 2014
Processing time: 230 Days and 20.8 Hours
Revised: November 28, 2013
Accepted: January 19, 2014
Published online: May 14, 2014
Processing time: 230 Days and 20.8 Hours
Core Tip
Core tip: This article provides a review of therapeutic agents and therapies that have been used in the treatment of Helicobacter pylori infection. Factors that may affect treatment outcome are described and therapeutic strategy is recommended.